Understand market dynamics, quantify opportunities, assess competitive landscapes, and evaluate the factors shaping market growth through comprehensive, evidence-based analysis.
A successful strategy begins with a clear understanding of the market. Our Market Landscape Assessments provide a comprehensive view of the healthcare ecosystem, helping organizations evaluate market dynamics, identify opportunities, understand customer behavior, and make informed commercial and investment decisions. Typical turnaround is 2–3 weeks.
Our specialty is the KOL interview layer — uncovering the insight that published sources alone will not give you.
What does this market actually look like before we commit to entering it?
Reliable market sizing requires more than applying industry growth rates. We develop robust, evidence-based estimates by triangulating multiple data sources, healthcare datasets, and primary research.
Establish a clear market definition — product scope, target indications, customer segments, and geographic boundaries — so the assessment reflects the true addressable opportunity.
Develop a tailored sizing methodology using the most appropriate combination of approaches:
Every model is validated through multiple independent evidence sources to improve accuracy and reliability:
Project future potential by evaluating the variables most likely to influence growth:
The success of a healthcare product depends not only on demand but on the infrastructure required to deliver care. We map the ecosystem so you can see where opportunities exist and where infrastructure gaps may limit adoption.
Assess the facilities and care settings relevant to your product or therapy:
Evaluate the professionals responsible for diagnosis, treatment, and product adoption:
Understanding the true size of a disease population or procedure market is critical for evaluating opportunities and planning entry. We build reliable estimates even where published data is scarce.
Payors, reimbursement amounts, and pricing dynamics across target markets.
Foundational intelligence on the evolving patient journey for R&D and commercial teams.
Delivered a comprehensive market opportunity assessment for an early-stage MedTech startup, enabling informed investment and commercialization decisions for a novel endoscope designed for PCNL procedures.
Quantified the US and European market opportunity for a novel CRT (cardiac resynchronization therapy) optimization system and translated physician feedback into a credible commercial and exit narrative for fundraising.
Built an evidence-based market entry strategy for an advanced wound-management solution entering Sweden — sizing the opportunity, mapping regulatory and reimbursement requirements, and identifying the KOLs and distributors needed to launch.
Tell us the decision you're facing and we'll scope an evidence-based approach.
Evidence-led market intelligence, commercialization & clinical evidence for MedTech and BioTech.
contactus@soralifesciences.com© 2026 Sora Life Sciences. All rights reserved.